PARCA (a digital tool) to improve Justice and Health
PARCA(数字工具)改善司法和健康
基本信息
- 批准号:10483296
- 负责人:
- 金额:$ 25.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnalgesicsAppointmentAreaAwarenessCaringCase ManagerClientClinicalCommunicationCommunitiesCountyDataDevelopmentDiseaseDisparateEffectivenessEnvironmentEventFailureGeneral PopulationGoalsHealthHealth TechnologyHeroinHousingIndividualInterventionInterviewInvestmentsJusticeLearningLegal patentLengthLettersLinkLocationMeasuresMedicalNaloxoneOpioidOutcomeOxycodonePersonsPhasePopulationPositioning AttributeProcessProgress ReportsPublic HealthRandomizedResearchResourcesSelf ManagementServicesSmall Business Technology Transfer ResearchSubstance AddictionSupervisionSupport GroupsSystemTechnologyTestingTexasTimeUnited StatesWorkacceptability and feasibilitycostcost comparisoncriminal behaviordashboarddesigndigital healthdigital tooleffectiveness evaluationeffectiveness studyexperiencefollow-upimprovedinsightmedication for opioid use disordermobile applicationnovelopioid useopioid use disorderoverdose preventionparoleparoleeprimary outcomeprobationprobationerrearrestrecidivismrecruitrelapse preventionretention ratesecondary outcomeservice providerssharing platformsocial health determinantssubstance usesubstance use treatmentsuccesstreatment programtreatment servicesuser centered design
项目摘要
PROJECT SUMMARY/ABSTRACT
Nearly 4.4 million individuals are on community supervision in the United States, with the majority (about
80%) being supervised under probation.1 Justice involved persons (JIPs) have a 474% increased lifetime
experience with heroin, a 303% increased use of OxyContin in the last 12 months, and a 256% increased use in
pain medication in the last 12 months, compared to the general population.3 One important step in addressing
substance use and addiction is getting individuals engaged in the treatment process, as initiation and retention
rates are very low for substance use treatment among this population. Q2i successfully developed the
Probation/Parole And Reentry Coach Application (PARCA) technology, which includes a Justice Team (JT)
Dashboard connected to a mobile app designed for JIPs. The platform enables JIPs to set and manage their
personal goals while assisting them in addressing the social determinants of health (SDOH) in order to
facilitate and supplement the substance use treatment process. It provides a step-by-step guide and identifies
local services and resources that the JIPs can connect with to accomplish these goals. At the same time, it gives
the JT a dashboard that enables greater insight on how a JIP is managing their plan. This increased connection
and communication between the JT and the JIP is designed to improve the community supervision process. In
this Phase 1/Phase 2 Fast Track STTR application, Q2i’s PARCA platform will be refined and implemented in
Dallas and Hidalgo Counties to test its efficacy. The primary goal of Phase I is to enhance the PARCA
platform for JIP. The study team will accomplish this by recruiting three sets of 2 PPOs/Case Managers willing
to use PARCA with five of their clients who have used any opioids in the last 12 months (total JIPs = 30) for 2-
weeks. The team will conduct interviews with PPOs and their clients that will inform our user-centered design
iterations. Initial interviews will describe barriers and challenges to successful community supervision
including accessing MOUD treatment and how PARCA can be improved to address these challenges. Follow-
up interviews will describe feasibility (use of the PARCA platform features) and acceptability (engagement
with PARCA platform through user engagement logs) of using PARCA platform to locate and access MOUD
treatment. The overall goal of Phase II is to test the relative efficacy of supervision as usual (SAU) and
PARCA in helping JIPs under community supervision engage in substance use treatment process and reduce
subsequent involvement in criminal behavior. Using a stepped wedge effectiveness design, we will evaluate the
PARCA platform across probation/parole officers (PPOs) (N=60), probationers/parolees (N=600). PPOs will
be randomized in three clusters of 20 people to utilize PARCA. Lastly, we will assess the acceptability and
feasibility of PARCA platform by supervision officers and justice-involved persons (JIPs) and whether
PARCA improves the working alliance between supervisors and JIPs.
项目概要/摘要
在美国,有近 440 万人接受社区监督,其中大多数(约
80%) 受到缓刑监督。1 司法相关人员 (JIP) 的寿命延长了 474%
吸食海洛因的经验,过去 12 个月内奥施康定的使用量增加了 303%,以及过去 12 个月内奥施康定的使用量增加了 256%
与一般人群相比,过去 12 个月内服用止痛药的情况。3 解决这一问题的重要一步
物质使用和成瘾使个人参与治疗过程,作为启动和保留
该人群的药物滥用治疗率非常低,Q2i 成功开发了该药物。
缓刑/假释和重返校园教练应用程序 (PARCA) 技术,其中包括司法团队 (JT)
连接到专为 JIP 设计的移动应用程序的仪表板使 JIP 能够设置和管理其设备。
个人目标,同时协助他们解决健康的社会决定因素 (SDOH),以便
它提供了分步指南并确定了药物使用治疗过程的便利和补充。
JIP 可以连接以实现这些目标的本地服务和资源。
JT 是一个仪表板,可让您更深入地了解 JIP 如何管理其计划。这增强了联系。
JT 和 JIP 之间的沟通旨在改善社区监督流程。
在这一阶段 1/阶段 2 快速通道 STTR 应用中,Q2i 的 PARCA 平台将在
达拉斯县和伊达尔戈县测试其功效 第一阶段的主要目标是增强 PARCA。
研究团队将通过招募三组愿意的 PPO/案例经理来实现这一目标。
与过去 12 个月内使用过任何阿片类药物的 5 名客户一起使用 PARCA(总 JIP = 30)2-
该团队将与 PPO 及其客户进行访谈,为我们以用户为中心的设计提供信息。
初始访谈将描述成功社区监督的障碍和挑战。
包括接受 MOUD 治疗以及如何改进 PARCA 来应对这些挑战。
up 访谈将描述可行性(PARCA 平台功能的使用)和可接受性(参与度)
使用 PARCA 平台(通过用户参与日志)使用 PARCA 平台定位和访问 MOUD
相对II期治疗的总体目标是测试照常监督(SAU)和治疗的效果。
PARCA 帮助社区监督下的 JIP 参与药物使用治疗过程并减少
我们将使用阶梯式楔形有效性设计来评估随后参与的犯罪行为。
PARCA 平台涵盖缓刑/假释官员 (PPO) (N=60)、缓刑犯/假释者 (N=600)。
被随机分为三组,每组 20 人以利用 PARCA 最后,我们将评估其可接受性和有效性。
监督官员和司法相关人员(JIP)建立 PARCA 平台的可行性以及是否
PARCA 改善了主管和 JIP 之间的工作联盟。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Faye S Taxman其他文献
Predictors of mental health among U.S. adults during COVID-19 early pandemic, mid- pandemic, and post-vaccine eras
COVID-19 大流行早期、大流行中期和后疫苗时代美国成年人心理健康的预测因素
- DOI:
10.1186/s12889-024-17781-x - 发表时间:
2024-02-29 - 期刊:
- 影响因子:4.5
- 作者:
Niloofar Ramezani;Bruce G. Taylor;Elizabeth Flanagan Balawajder;Kai MacLean;Harold A. Pollack;John A Schneider;Faye S Taxman - 通讯作者:
Faye S Taxman
Openness to change among COVID misinformation endorsers: Associations with social demographic characteristics and information source usage.
新冠病毒错误信息支持者对变革的开放态度:与社会人口特征和信息源使用的关联。
- DOI:
10.1016/j.socscimed.2023.116233 - 发表时间:
2023-09-01 - 期刊:
- 影响因子:5.4
- 作者:
Xiao;Urszula A. Horoszko;Amy Murphy;Bruce Taylor;Phoebe A. Lamuda;Harold A. Pollack;John A Schneider;Faye S Taxman - 通讯作者:
Faye S Taxman
Endorsement of COVID-19 misinformation among criminal legal involved individuals in the United States: Prevalence and relationship with information sources
美国刑事法律相关个人对 COVID-19 错误信息的认可:流行程度及其与信息来源的关系
- DOI:
10.1371/journal.pone.0296752 - 发表时间:
2024 - 期刊:
- 影响因子:3.7
- 作者:
Xiao;Aayushi Hingle;Cameron C Shaw;Amy Murphy;Breonna R Riddick;Rochelle R Davidson Mhonde;Bruce G. Taylor;Phoebe A. Lamuda;Harold A Pollack;John A Schneider;Faye S Taxman - 通讯作者:
Faye S Taxman
Faye S Taxman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Faye S Taxman', 18)}}的其他基金
HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance Uptake
HEAL 加速器:利用合作伙伴关系和有针对性的传播来促进吸收
- 批准号:
10915749 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance Uptake
HEAL 加速器:利用合作伙伴关系和有针对性的传播来促进吸收
- 批准号:
10667038 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Implementation and Translation Research Project Core
实施和翻译研究项目核心
- 批准号:
10219226 - 财政年份:2019
- 资助金额:
$ 25.6万 - 项目类别:
Implementation and Translation Research Project Core
实施和翻译研究项目核心
- 批准号:
10696068 - 财政年份:2019
- 资助金额:
$ 25.6万 - 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
- 批准号:
8236911 - 财政年份:2011
- 资助金额:
$ 25.6万 - 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
- 批准号:
8607919 - 财政年份:2011
- 资助金额:
$ 25.6万 - 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
- 批准号:
8661519 - 财政年份:2011
- 资助金额:
$ 25.6万 - 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
- 批准号:
8304729 - 财政年份:2011
- 资助金额:
$ 25.6万 - 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
- 批准号:
8041981 - 财政年份:2011
- 资助金额:
$ 25.6万 - 项目类别:
相似国自然基金
芳基氨甲基-哌啶/四氢萘类μ/δ阿片受体双重功效镇痛分子成药性研究
- 批准号:81773635
- 批准年份:2017
- 资助金额:48.0 万元
- 项目类别:面上项目
长效阿片类镇痛药物镇痛与依赖分离的机制研究
- 批准号:81402911
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
运用代谢组学技术系统研究乌头碱类镇痛药的体内活性/毒性代谢产物
- 批准号:81302844
- 批准年份:2013
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
δ、μ、κ 阿片受体三重激动剂的作用机制研究
- 批准号:81173029
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
去甲肾上腺素α2A受体的镇痛调节新靶点- - -CSK
- 批准号:81072626
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
相似海外基金
COVID-19 Impact on Pain management: Highlighting, Explaining, and Realigning services (CIPHER)
COVID-19 对疼痛管理的影响:突出显示、解释和重新调整服务 (CIPHER)
- 批准号:
10412749 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
COVID-19 Impact on Pain management: Highlighting, Explaining, and Realigning services (CIPHER)
COVID-19 对疼痛管理的影响:突出显示、解释和重新调整服务 (CIPHER)
- 批准号:
10595645 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functional Outcomes among Primary Care Veterans
针对慢性疼痛的简短认知行为疗法可改善初级保健退伍军人的功能结果
- 批准号:
10391340 - 财政年份:2021
- 资助金额:
$ 25.6万 - 项目类别:
Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functional Outcomes amongPrimary Care Veterans
针对慢性疼痛的简短认知行为疗法可改善初级保健退伍军人的功能结果
- 批准号:
10664836 - 财政年份:2021
- 资助金额:
$ 25.6万 - 项目类别:
Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functional Outcomes amongPrimary Care Veterans
针对慢性疼痛的简短认知行为疗法可改善初级保健退伍军人的功能结果
- 批准号:
10664836 - 财政年份:2021
- 资助金额:
$ 25.6万 - 项目类别: